8EDH

Identification of a class of WNK isoform-specific inhibitors through high-throughput screening


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.11 Å
  • R-Value Free: 0.291 
  • R-Value Work: 0.186 

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 2.1 of the entry. See complete history


Literature

Identification of a Class of WNK Isoform-Specific Inhibitors Through High-Throughput Screening.

Chlebowicz, J.Akella, R.Humphreys, J.M.He, H.Kannangara, A.R.Wei, S.Posner, B.Goldsmith, E.J.

(2023) Drug Des Devel Ther 17: 93-105

  • DOI: https://doi.org/10.2147/DDDT.S389461
  • Primary Citation of Related Structures:  
    8EDH

  • PubMed Abstract: 

    WNK [with no lysine (K)] kinases are serine/threonine kinases associated with familial hyperkalemic hypertension (FHHt). WNKs are therapeutic targets for blood pressure regulation, stroke and several cancers including triple negative breast cancer and glioblastoma. Here, we searched for and characterized novel WNK kinase inhibitors.


  • Organizational Affiliation

    Department of Biophysics, The University of Texas Southwestern Medical Center, Dallas, TX, USA.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Serine/threonine-protein kinase WNK3A,
B [auth C]
292Homo sapiensMutation(s): 1 
Gene Names: WNK3KIAA1566PRKWNK3
EC: 2.7.11.1
UniProt & NIH Common Fund Data Resources
Find proteins for Q9BYP7 (Homo sapiens)
Explore Q9BYP7 
Go to UniProtKB:  Q9BYP7
PHAROS:  Q9BYP7
GTEx:  ENSG00000196632 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ9BYP7
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
WGK (Subject of Investigation/LOI)
Query on WGK

Download Ideal Coordinates CCD File 
C [auth A]ethyl 1-(5,7-dimethoxy-4-methylquinolin-2-yl)piperidine-4-carboxylate
C20 H26 N2 O4
QMSAXOQPCCJWDP-UHFFFAOYSA-N
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.11 Å
  • R-Value Free: 0.291 
  • R-Value Work: 0.186 
  • Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 50.976α = 90
b = 112.473β = 100.268
c = 66.642γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
HKL-3000data reduction
HKL-3000data scaling
MOLREPphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Cancer Prevention and Research Institute of Texas (CPRIT)United StatesRP190421

Revision History  (Full details and data files)

  • Version 1.0: 2023-03-01
    Type: Initial release
  • Version 2.0: 2023-04-26
    Changes: Advisory, Atomic model, Database references, Derived calculations, Polymer sequence, Refinement description, Source and taxonomy, Structure summary
  • Version 2.1: 2023-10-25
    Changes: Data collection, Refinement description